Chief Business Officer
Chung Jin-ho has recently joined NanoMediTech as Chief Business Officer. Mr. Chung has worked as a business development officer in the biotechnology and pharmaceuticals industry for over 18 years, with extensive experience in licensing. He will be responsible for NanoMediTech’s commercial evaluation and due diligence teams and for negotiating partner agreements.
Mr. Chung has previously worked for Daewoo Pharmaceuticals, Alkermes and Merck where he gained invaluable expertise in negotiating and executing agreements throughout the world. He has extensive experience in biotech licensing and patenting.
Mr. Chung holds a BSc in Microbiology from Gwangju Institute of Science and Technology and an MBA from Yonsei University.